{"id":"olopatadine-0-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Ocular irritation"},{"rate":null,"effect":"Blurred vision"},{"rate":null,"effect":"Dry eye"},{"rate":null,"effect":"Keratitis"}]},"_chembl":{"chemblId":"CHEMBL1189432","moleculeType":"Small molecule","molecularWeight":"337.42"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Olopatadine works through dual action: it blocks histamine H1 receptors on ocular tissues to prevent histamine-mediated allergic responses, and it stabilizes mast cells to reduce the release of inflammatory mediators. This combination provides rapid symptom relief and sustained control of allergic conjunctivitis symptoms including itching, redness, and tearing.","oneSentence":"Olopatadine is a selective H1-receptor antagonist and mast cell stabilizer that reduces allergic inflammation in the eye.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:58:05.235Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic conjunctivitis"},{"name":"Itching associated with allergic conjunctivitis"}]},"trialDetails":[{"nctId":"NCT03186755","phase":"PHASE4","title":"Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis","status":"UNKNOWN","sponsor":"Michael Marchand, MD","startDate":"2017-06-11","conditions":"Conjunctivitis, Allergic, Conjunctivitis, Vernal","enrollment":42},{"nctId":"NCT02478398","phase":"PHASE3","title":"Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-07-20","conditions":"Rhinitis, Allergic, Seasonal","enrollment":1025},{"nctId":"NCT02322216","phase":"PHASE3","title":"Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2014-12","conditions":"Allergic Conjunctivitis","enrollment":383},{"nctId":"NCT01700192","phase":"PHASE3","title":"Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2013-01","conditions":"Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Nonseasonal","enrollment":1482},{"nctId":"NCT00562159","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":439},{"nctId":"NCT00550550","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":345},{"nctId":"NCT02251613","phase":"PHASE4","title":"Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2013-12","conditions":"Allergic Conjunctivitis","enrollment":50},{"nctId":"NCT01109485","phase":"PHASE4","title":"Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2010-03","conditions":"Allergic Conjunctivitis","enrollment":42},{"nctId":"NCT01363700","phase":"PHASE3","title":"Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Santen Pharmaceutical Co., Ltd.","startDate":"","conditions":"Allergic Conjunctivitis","enrollment":87},{"nctId":"NCT01743027","phase":"PHASE3","title":"Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2013-01","conditions":"Allergic Conjunctivitis","enrollment":902},{"nctId":"NCT00987272","phase":"PHASE3","title":"Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2009-10","conditions":"Allergic Conjunctivitis","enrollment":267},{"nctId":"NCT01119287","phase":"PHASE4","title":"Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2010-03","conditions":"Allergic Conjunctivitis","enrollment":180},{"nctId":"NCT01732757","phase":"PHASE4","title":"A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Allergan","startDate":"2012-11","conditions":"Conjunctivitis, Allergic","enrollment":157},{"nctId":"NCT01470118","phase":"PHASE4","title":"A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Allergan","startDate":"2011-10","conditions":"Conjunctivitis, Allergic","enrollment":127},{"nctId":"NCT01282138","phase":"PHASE4","title":"Assessment of Alcon's Ocular Image Quantification System","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2010-12","conditions":"Allergic Conjunctivitis","enrollment":13},{"nctId":"NCT00818805","phase":"PHASE4","title":"Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2008-07","conditions":"Allergic Conjunctivitis","enrollment":50},{"nctId":"NCT01344083","phase":"PHASE2","title":"Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Laboratoires Thea","startDate":"2011-04","conditions":"Seasonal Allergic Conjunctivitis","enrollment":60},{"nctId":"NCT01435460","phase":"PHASE3","title":"Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2010-08","conditions":"Seasonal Allergic Conjunctivitis","enrollment":300},{"nctId":"NCT01258309","phase":"PHASE3","title":"Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Allergan","startDate":"2010-12","conditions":"Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic","enrollment":129},{"nctId":"NCT00845195","phase":"PHASE4","title":"Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2009-03","conditions":"Seasonal Allergic Rhinitis","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":41,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Patanol"],"phase":"marketed","status":"active","brandName":"Olopatadine 0.1%","genericName":"Olopatadine 0.1%","companyName":"Bausch & Lomb Incorporated","companyId":"bausch-lomb-incorporated","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Olopatadine is a selective H1-receptor antagonist and mast cell stabilizer that reduces allergic inflammation in the eye. Used for Allergic conjunctivitis, Itching associated with allergic conjunctivitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}